Status:
RECRUITING
Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
Lead Sponsor:
Cairo University
Conditions:
Placenta Accreta Spectrum
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.
Eligibility Criteria
Inclusion
- Pregnancy of singleton living fetus
- Previous one or more cesarean sections
- Gestational age: \> 32 weeks
- The following ultrasound markers such as "loss of clear retroplacental translucency", "myometrial thinning", "abnormal lacunae", "irregular bladder wall", "utero-vesicalhypervascularity".
- Preoperative hemoglobin more than 10 gm/dl
- Cases with PAS that will undergoing CS Hysterectomy
Exclusion
- Maternal medical disorders e.g.: coagulation defects, cardiac diseases etc.….
- Any known or reported hypersensitivity to the used medication.
- All cases with spontaneous placental separation at laparotomy.
- All patients undergoing conservative management of PAS.
- All cases which necessitate emergency termination.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06493968
Start Date
July 1 2024
End Date
December 31 2024
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt